FDA Adverse Event Injury Summary report: N

MICROTRANSPONDER® VIVISTIM® PAIRED VNS¿ SYSTEM (VIVISTIM® SYSTEM)

MDR report key: 17380118 · Received July 24, 2023

Report

Report Number
3012309950-2023-00002
Event Type
Injury
Date Received
July 24, 2023
Date of Event
June 29, 2023
Report Date
July 21, 2023
Manufacturer
MICROTRANSPONDER INC.
Product Code
QPY
UDI-DI
10810041430066
PMA / PMN Number
P210007
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Description of Event or Problem · 0

PATIENT REPORTED COUGHING, HOARSENESS AND DIFFICULTY HAVING CONVERSATIONS POST IMPLANT. THE PATIENT FOLLOWED UP WITH IMPLANTING PHYSICIAN AND CONSULTED A VOICE DISORDER SPECIALIST. PER THE PATIENT, THEY HAD VOCAL CORD FILLER AND SYMPTOMS HAVE IMPROVED. DEVICE HISTORY RECORDS WERE REVIEWED FOR IPG S/N (B)(6) AND LEAD S/N (B)(6). THE DEVICES PASSED ALL FUNCTIONAL SPECIFICATIONS AND QUALITY TESTS AND WERE STERILIZED PRIOR TO DISTRIBUTION. NO OTHER RELEVANT INFORMATION HAS BEEN RECEIVED TO DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1271819 MICROTRANSPONDER® VIVISTIM® PAIRED VNS¿ SYSTEM (VIVISTIM® SYSTEM) VIVISTIM® SYSTEM QPY MICROTRANSPONDER INC. MODEL 3000 10810041430066

Patients

Seq Age Sex Outcome Treatment
1 58 YR Female Required Intervention